These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28466570)

  • 1. Physical activity, obesity and survival in diffuse large B-cell and follicular lymphoma cases.
    Boyle T; Connors JM; Gascoyne RD; Berry BR; Sehn LH; Bashash M; Spinelli JJ
    Br J Haematol; 2017 Aug; 178(3):442-447. PubMed ID: 28466570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
    Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE
    Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma.
    Magnano L; Balagué O; Dlouhy I; Rovira J; Karube K; Pinyol M; Rivas-Delgado A; Costa D; Martínez-Trillos A; González-Farre B; Martínez-Pozo A; Giné E; Colomer D; Delgado J; Villamor N; Campo E; López-Guillermo A
    Ann Oncol; 2017 Nov; 28(11):2799-2805. PubMed ID: 29045517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of autoimmune disease affects not only risk but also survival in patients with B-cell non-Hodgkin lymphoma.
    Kleinstern G; Averbuch M; Abu Seir R; Perlman R; Ben Yehuda D; Paltiel O
    Hematol Oncol; 2018 Apr; 36(2):457-462. PubMed ID: 29469175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index and outcomes in patients receiving chemotherapy for intermediate-grade B-cell non-Hodgkin lymphoma.
    Jones JA; Fayad LE; Elting LS; Rodriguez MA
    Leuk Lymphoma; 2010 Sep; 51(9):1649-57. PubMed ID: 20807093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab use and survival after diffuse large B-cell or follicular lymphoma: a population-based study.
    Keegan TH; Moy LM; Foran JM; Alizadeh AA; Chang ET; Shema SJ; Schupp CW; Clarke CA; Glaser SL
    Leuk Lymphoma; 2013 Apr; 54(4):743-51. PubMed ID: 22957852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the International Prognostic Index: new prognostic factors in follicular lymphoma and diffuse large-cell lymphoma A meeting report of the Second International Lunenburg Lymphoma Workshop.
    Kersten MJ; Jong Dd Dd; Raemaekers JM; Kluin PM; Hagenbeek A
    Hematol J; 2004; 5(3):202-8. PubMed ID: 15167905
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group.
    Provencio M; Royuela A; Torrente M; Pollán M; Gómez-Codina J; Sabín P; Llanos M; Gumá J; Quero C; Blasco A; Aguiar D; García-Arroyo FR; Lavernia J; Martínez N; Morales M; Saenz-Cusi Á; Rodríguez D; Calvo V; de la Cruz-Merino L; de la Cruz MÁ; Rueda A;
    Cancer; 2017 Oct; 123(19):3709-3716. PubMed ID: 28608996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
    Cerhan JR; Bernstein L; Severson RK; Davis S; Colt JS; Blair A; Hartge P
    Cancer Causes Control; 2005 Dec; 16(10):1203-14. PubMed ID: 16215871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased body mass index is associated with improved survival in United States veterans with diffuse large B-cell lymphoma.
    Carson KR; Bartlett NL; McDonald JR; Luo S; Zeringue A; Liu J; Fu Q; Chang SH; Colditz GA
    J Clin Oncol; 2012 Sep; 30(26):3217-22. PubMed ID: 22649138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis.
    Lerch K; Meyer AH; Stroux A; Hirt C; Keller U; Viardot A; Marks R; Schreiber S; Pezzutto A; Scholz CW
    Ann Hematol; 2015 Jun; 94(6):981-8. PubMed ID: 25645656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison between CHOP-like and R-CHOP in diffuse large B cell and follicular lymphoma].
    Oliver C; Guillermo C; Martínez P; Díaz L
    Rev Med Chil; 2013 Jul; 141(7):844-52. PubMed ID: 24356732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapy.
    Maeshima AM; Taniguchi H; Fukuhara S; Morikawa N; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
    Am J Surg Pathol; 2013 Apr; 37(4):563-70. PubMed ID: 23426122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and risk of non-Hodgkin lymphoma (United States).
    Chiu BC; Soni L; Gapstur SM; Fought AJ; Evens AM; Weisenburger DD
    Cancer Causes Control; 2007 Aug; 18(6):677-85. PubMed ID: 17484069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV Infection and Survival of Lymphoma Patients in the Era of Highly Active Antiretroviral Therapy.
    Han X; Jemal A; Hulland E; Simard EP; Nastoupil L; Ward E; Flowers CR
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):303-311. PubMed ID: 27756777
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence, risk factors and outcome of histological transformation in follicular lymphoma.
    Conconi A; Ponzio C; Lobetti-Bodoni C; Motta M; Rancoita PM; Stathis A; Moccia AA; Mazzucchelli L; Bertoni F; Ghielmini M; Cavalli F; Zucca E
    Br J Haematol; 2012 Apr; 157(2):188-96. PubMed ID: 22348437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of surveillance computed tomography in the follow-up of diffuse large B-cell and follicular lymphomas.
    Lin TL; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Tang TC; Chang H; Hung YS; Lu SC
    Ann Hematol; 2012 Nov; 91(11):1741-5. PubMed ID: 22729139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.
    Tada K; Kim SW; Asakura Y; Hiramoto N; Yakushijin K; Kurosawa S; Tajima K; Mori S; Heike Y; Tanosaki R; Maeshima AM; Taniguchi H; Furuta K; Kagami Y; Matsuno Y; Tobinai K; Takaue Y; Fukuda T
    Am J Hematol; 2012 Aug; 87(8):770-5. PubMed ID: 22641292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.
    Kridel R; Telio D; Villa D; Sehn LH; Gerrie AS; Shenkier T; Klasa R; Slack GW; Tan K; Gascoyne RD; Connors JM; Savage KJ
    Br J Haematol; 2017 Jan; 176(2):210-221. PubMed ID: 27739058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.